From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

  1. Home>
  2. Specialties>
  3. General Medicine>
  4. Summary and Comment

What's the Preferred First-Line Treatment for Allergic Rhinitis?

Sufferers from allergic rhinitis now enjoy a wide array of therapies for their bothersome affliction, leading to uncertainty about which ones work best. The most commonly prescribed medications are intranasal corticosteroids and oral antihistamines. These investigators performed a meta-analysis to assess the comparative effects of these two therapies on different allergic symptoms.

A total of 16 randomized, controlled trials with 2,267 subjects were evaluated. Outcomes included nasal symptoms (blockage, discharge, sneezing, itch, postnansal drip, discomfort, resistance, and total nasal symptoms), eye symptoms, and global assessment. Steroids gave significantly more relief than antihistamines for nasal blockage, discharge, sneezing, itch, postnasal drip, and total nasal symptoms. Compared with antihistamines, steroids had an odds ratio of 0.26 for deterioration of symptoms, according to global ratings. There were no differences between treatments for nasal discomfort, nasal resistance, and eye symptoms. All 3 studies that evaluated cost-effectiveness favored nasal steroids.

Comment: Although part of the analysis was confounded by the inclusion of studies with differences in scoring symptoms, the majority of the findings were very strong. These findings, coupled with safety data and cost-effectiveness data, make it clear that nasal steroids deserve to be first-line therapy for allergic rhinitis. A large recently published trial came to the same conclusion as this meta-analysis (see JW Oct 1 1998, p. 152, accession number 980908001, and J Fam Pract 1998; 47:118).

— KI Marton

Published in Journal Watch General Medicine January 26, 1999

Citation(s):

Weiner JM et al. Intranasal corticosteroids versus oral H1 receptor antagonists in allergic rhinitis: Systematic review of randomised controlled trials. BMJ 1998 Dec 12 317 1624-1629.

Your Remark:

Reader Remarks are intended to encourage lively discussion of clinical topics with your peers in the medical community. Please consider this when composing your remark.

Fields marked with an * are required.

Name as you'd like it to appear:

Submitting a comment indicates you have read and agreed to the remark guidelines and declare:*

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

 

CLEAR erases anything you've added in any part of the form. CONTINUE allows you to check your entire post (and edit it if necessary) before submitting.

To ensure that your Reader Remark is not formatted as one long paragraph, precede new paragraphs with either a blank line or an indentation.

Search

Advanced

Article Tools

Reader Remarks

Sign-In

Forgot your password?

New to Journal Watch?

E-mail Alerts

Delivered to your inbox.
Tailored to your interests. Free.

Sign Up Now!

Journal Watch Newsletters

Available in 13 specialties with convenient delivery and 10 free online CME exams.

Subscribe Now!

Copyright © 1999. Massachusetts Medical Society. All rights reserved.